CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine.
Saved in:
| Title: | CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine. |
|---|---|
| Authors: | Accolla RS; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy., Ramia E; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy., Tedeschi A; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy., Forlani G; Laboratories of General Pathology and Immunology 'Giovanna Tosi', Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy. |
| Source: | Frontiers in immunology [Front Immunol] 2019 Jul 30; Vol. 10, pp. 1806. Date of Electronic Publication: 2019 Jul 30 (Print Publication: 2019). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2019.01806 |
